Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis

被引:54
作者
Zhang, Z.-C.
Li, S.-J.
Yang, Y.-Z.
Chen, R.-Z.
Ge, J.-B.
Chen, H.-Z.
机构
[1] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Minist Publ Hlth,Key Lab Viral Heart Dis, Shanghai 200032, Peoples R China
[2] Zhejiang Hosp, Hangzhou 310013, Zhenjiang Provi, Peoples R China
基金
中国国家自然科学基金;
关键词
astragaloside; apoptosis; coxsackievirus B (CVB); myocarditis; microarray;
D O I
10.1080/10286020412331286506
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Astragaloside is the major component of Astragalus membranaceus, one of the Chinese medical herbs, and has several pharmacological actions on cardiovascular system, including positive inotropic, antiarrhythmia and anti-oxidant activities. We have investigated the effect of astragaloside on cardiomyocyte apoptosis and expression of apoptosis-associated genes in mice with coxsackievirus B-3 (CVB3)-induced myocarditis, the former of which has been detected by terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay and the latter determined by using a focused microarray. Results showed that cardiomyocyte apoptosis and expression of various apoptosis associated genes are inhibited after treatment with astragaloside. The anti-apoptotic activity of astragaloside may contribute to the improvement of clinical outcomes in treating myocarditis with pharmaceutics of Astragalus membranaceus.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 14 条
  • [11] Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis
    Saraste, A
    Arola, A
    Vuorinen, T
    Kytö, V
    Kallajoki, M
    Pulkki, K
    Voipio-Pulkki, LM
    Hyypiä, T
    [J]. CARDIOVASCULAR PATHOLOGY, 2003, 12 (05) : 255 - 262
  • [12] Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L, CD30L, OX40L and 4-1BBL in the heart of patients with acute myocarditis and dilated cardiomyopathy
    Seko, Y
    Ishiyama, S
    Nishikawa, T
    Kasajima, T
    Hiroe, M
    Suzuki, S
    Ishiwata, S
    Kawai, S
    Tanaka, Y
    Azuma, M
    Kobata, T
    Yagita, H
    Okumura, K
    Nagai, R
    [J]. CARDIOVASCULAR PATHOLOGY, 2002, 11 (03) : 166 - 170
  • [13] SHEN XT, 1993, ACTA PHARM SIN, V14, P95
  • [14] [Zhang Zhaocai 张召才], 2003, [中国新药与临床杂志, Chinese Journal of New Drugs and Clinical Remedies], V22, P515